Literature DB >> 3896819

Measurement of parasite-specific immune responses in vitro: evidence for suppression of the antibody response to Trypanosoma cruzi.

R L Tarleton, R E Kuhn.   

Abstract

Using the Mishell and Dutton culture system, we have developed an assay for eliciting and quantifying parasite-specific immune responses in vitro. The ability of spleen cells from noninfected and Trypanosoma cruzi-infected mice to respond to parasite-associated antigens was assessed by examining the primary plaque-forming cell response to trinitrophenylated T. cruzi (TNP-TC). The response to TNP-TC of both normal, noninfected, unprimed mice and mice infected with T. cruzi is T cell dependent and appeared to involve recognition of parasite antigens by T. cruzi-specific T cells. In most experiments, spleen cells from infected mice respond to TNP-TC at levels equal to, or below, that of spleen cells from normal mice. This near "normal" response is in apparent contrast to the suppressed response of spleen cells from infected mice to another antigen (sheep red blood cells) or TNP on a different carrier (TNP-chicken erythrocytes). Demonstration that the response of spleen cells from infected mice to TNP-TC can be potentiated by addition of interleukin 2-containing supernatants or by depletion of plastic and Sephadex G-10-adherent cells suggests that the mechanisms which control the response of infected mice to nonparasite antigens may also limit parasite-specific immune responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896819     DOI: 10.1002/eji.1830150820

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Repeated antigenic stimulation overcomes immunosuppression in experimental Chagas' disease.

Authors:  L Choromanski; R E Kuhn
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

2.  Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection.

Authors:  E Zuñiga; C Motran; C L Montes; F L Diaz; J L Bocco; A Gruppi
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

3.  Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease.

Authors:  M R Grauert; M Houdayer; M Hontebeyrie-Joskowciz
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

4.  Effect of elevated environmental temperature on the antibody response of mice to Trypanosoma cruzi during the acute phase of infection.

Authors:  K A Dimock; C D Davis; R E Kuhn
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 5.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  Effect of antigen-specific T helper cells or interleukin-2 on suppressive ability of macrophage subsets detected in spleens of Trypanosoma cruzi-infected mice as determined by limiting dilution-partition analysis.

Authors:  M C Cerrone; D M Ritter; R E Kuhn
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Tumour necrosis factor (cachectin) production during experimental Chagas' disease.

Authors:  R L Tarleton
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  Elevated environmental temperature enhances immunity in experimental Chagas' disease.

Authors:  K J Anderson; R E Kuhn
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

10.  Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy.

Authors:  Thaise Lara Teixeira; Fabrício Castro Machado; Aline Alves da Silva; Samuel Cota Teixeira; Bruna Cristina Borges; Marlus Alves Dos Santos; Flávia Alves Martins; Paula Cristina Brígido; Adele Aud Rodrigues; Ana Flávia Oliveira Notário; Bruno Antônio Ferreira; João Paulo Silva Servato; Simone Ramos Deconte; Daiana Silva Lopes; Veridiana Melo Rodrigues Ávila; Fernanda de Assis Araújo; Tatiana Carla Tomiosso; Marcelo José Barbosa Silva; Claudio Vieira da Silva
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.